Hypnotherapy in Functional Abdominal Pain Disorders

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

6 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The purpose of this study is to find out if a video-guided hypnotherapy (VGH) program will improve the symptoms of those with a functional abdominal pain disorder (FAPD). This program uses guided relaxation, intense concentration, and focused attention to achieve a heightened state of awareness. These techniques can be used to help some people change certain behaviors, and it is also used to treat chronic pain. VGH does not feature direct in-person interaction with a psychotherapist (mental health professional), but rather recorded sessions that can be viewed at any time at the discretion of the patient. This study will use the video-guided hypnotherapy program that has been developed by Jeffrey Lazarus, MD, FAAP. Dr. Lazarus is a general pediatrician with an extensive background in the use of clinical hypnosis in children. He has been certified as an Approved Consultant by the American Society of Clinical Hypnosis.

Who Do I Contact?

If you are interested in participating in the study or want to learn more please contact our study team at beniteza [at] chop.edu or 267-425-1937.

Eligibility & Criteria

IRB #:
20-017748
Official Title:
Use of video-guided hypnotherapy in patients with functional abdominal pain disorders
Study Phase:
Pilot
Eligible Age Range:
8 - 21 Years
Gender:
All
Study Categories:

Visit Criteria

You will be placed in one of two groups: the intervention group or the control group. If placed in the intervention group you will receive a link and instructions on how to use the VGH program and asked to use the program as often as you wish during 4 weeks. If placed in the control group you will continue to receive standard clinical care for four weeks and then receive instructions and the link to use the VGH program. You will be asked to report your symptoms in questionnaires weekly during the 4-week you are using the VGH program. Your study participation will occur from home.

If you agree to take part, your participation may be greater than 12 months. Your participation in this study will involve a screening period, 4-week intervention or control period, 4 follow up visits: one at the end of the intervention, and one at 3, 6 and 12 months after the end of the intervention.

The main risks of this study feeling uncomfortable sharing or answering questions about your symptoms. You may benefit if you follow the VGH program as instructed.

Participation in this study is voluntary. If you do not choose to take part in this study, you will still receive your care as scheduled, and you will not experience any interruptions in care. You may also be eligible for a different research study.